Day 1 - Monday, May 18 2026 - ET (Eastern Time, GMT-05:00)
This session provides a comprehensive overview of the four critical pricing metrics in the Medicaid Drug Rebate Program, explaining how Average Manufacturer Price (AMP), Average Sales Price (ASP), Best Price, and Unit Rebate Amount (URA) are calculated and their interconnected roles in government pricing compliance.
Deep dive into advanced topics related to your daily tasks and frustrations in your role:
- Breakdown of contract types and agreements
- Overview of contracting process and key stakeholders
- Basic pricing terminology and concepts (WAC, contract price, chargeback)
- Operational procedures for contract management
- Common chargeback errors
- Kristina Roach - Customer Success Officer, RevSavvy
- End-to-end transaction flow explanation
- Live invoice validation workshop with actual data examples
- How chargeback data flows impact government pricing calculations
- WAC to chargeback to final net price walkthrough
- System validations and checkpoints
- Manual vs. automated processes across major distributors
- Contract price update checklist and validation points
- Rosalind Davis - Head of Government Pricing and Market Access Operations, CSL Vifor
- Government discount forecasting in R&D investment models
- Best price risk assessment across development pipeline
- Medicaid rebate liability projections for budget planning
- Coverage gap redesign impact on portfolio ROI calculations
- Stephanie Kupski - Director, U.S. Pricing & Government Reporting, CSL Behring
- Learn to identify key patterns including reversals, sample prescriptions, and unusual transaction codes that impact rebate calculations
- Gain practical skills for systematic data review using real claim examples with manufacturer and PBM perspectives
- Build collaborative relationships with dedicated dispute personnel to resolve data quality issues more effectively
- Nichole Palusinski Pharm.D - Clinical Pharmacist, IL HFS Medicaid Drug Rebate Unit
- How to process state rebates, negotiation considerations, and operational workflows
- Josephine Hawkins - Associate Director, Medicaid, AstraZeneca
- Share leading practices in good-faith inquiries
- Understand the guidelines for manufacturer audits and the dispute resolution process
- Review results of recent HRSA audits of manufacturers and covered entities
- Describe the process for developing and implementing a successful corrective action plan (CAP)
- Sanaz Kelly, PharmD, MBA, 340B ACE - Associate Principal, Manufacturer Refund Service, Apexus
- State-by-state eligibility variation examples and management strategies
- GPO and PBM roster management fundamentals
- Tools and processes for eligibility verification, including automation
- Managing mixed-use accounts and classifications
- 340B eligibility basics and compliance considerations
- Best practices for maintaining clean membership data
- Setting up initial commercial infrastructure
- Contracting terms that have government pricing implications
- Basic wholesaler agreement components
- NDC setup through first commercial ship
- Key operational considerations for new products/companies
- Common pitfalls and how to avoid them
- Yasodhara Paruchuru - Head of Pricing & Contracting, Chiesi
- Erika Chiles - Pricing Contracting Trade Associate Director, Neurocrine BioSciences Inc
- Nick Laconi - Associate Director, Avyxa Pharma
- Real-world case studies from DTC rollouts, including decision criteria and early performance metrics
- Employer benefits perspective on DTC adoption barriers and why traditional rebate models remain preferred
- PBM competitive response strategies and impact on formulary positioning for DTC-participating products
- Patient access reality assessment: measuring actual savings versus marketing claims across different insurance designs
- Financial modeling framework comparing DTC margins to traditional channel rebate structures and volume projections
- Sharon Small - Director, Counsel Market Access, Government Pricing & Policy, Novartis Pharmaceuticals Corporation
Join this contextual session on the social and operational history of the program and watershed moments that crafted modern Medicaid operations
- Josephine Hawkins - Associate Director, Medicaid, AstraZeneca
Best practices for cross-functional pricing governance and decision-making frameworks
- Erika Chiles - Pricing Contracting Trade Associate Director, Neurocrine BioSciences Inc
- Jennifer Plemmons Crosswell - Director Contracts & Pricing, Azurity Pharmaceuticals
Join us for this deep dive workshop into the everchanging active and pending SPTR laws from the legal and operational perspectives.
- Trevor Wear - Partner, Sidley Austin LLP
Join your industry colleagues from large to small manufacturers during this 80 minute, informal and interactive discussion on your greatest barriers and pain points to drive results back at your organization. Benchmarking and open, led discussion on:
- MFN, MFP, Medicaid Part B, ASP, CMS final rule
- SPTR and PDAB requirements
- PBM vertical integration
- 340B rebate model
- Tara Brodo - Senior Director, Pricing and Contracting, Accord
Who do you contact with questions for errors? Who do you contact when you need details on the process for filing this and that? Sign up your team to meet your contacts at some of the top wholesalers nationwide. These meet-and-greets are for connecting and learning the processes and needs for each stakeholder to work collaboratively together.
- Amanda Bounds - Senior Director, Contract Administration, McKesson
- Julia Williams - Senior Manager, Contract Administration (MSH), McKesson
- Michael Connelly - Vice President, Pricing & Contract Management, Cencora
- Accounting for the common types of commercial contracts in your government pricing calculations
- Breaking down and understanding the core government pricing calculation components
- Quantifying the timing of price concessions in the calculations
- Scott Hoffman - Co-Founder & Head of Client Services, Woven Data
This foundational session covers Medicare Part B fundamentals including physician-administered drug reimbursement based on Average Sales Price (ASP) plus 6%, reporting requirements, and compliance considerations for manufacturers.
- Heath Ingram - Partner, Goodwin Procter LLP
- Melody Hamel - Senior Operations Counsel, Viatris Inc
Your introduction to Medicare Part D prescription drug benefit basics including plan formularies, coverage gap provisions, manufacturer discount programs, and the impact of IRA negotiations on Part D operations.
- Nick Laconi - Associate Director, Avyxa Pharma
- Identify the main statutory categories for how states calculate a “reportable” increase (lookback windows, baseline price definitions, averaging/lowest price rules, etc.)
- Translate those statutory differences into a decision tree that operational teams can apply before implementing a price change
- Use short numeric case studies to determine whether specific pricing moves would trigger state reporting obligations
- Marc Adler - President, Global Compliance Strategies
- Jennifer Allen - Senior Director, Compliance, Melinta Therapeutics
- Analyze reporting obligations and compliance timelines for states implementing SPTR programs in 2026
- Navigate first-year submission requirements and data collection processes for new state programs
- Implement validation systems specifically designed for emerging state transparency frameworks
- Develop tracking processes for newly enacted legislation and evolving regulatory guidance
- Create operational workflows to manage multi-state compliance across both established and new SPTR jurisdiction
- Bob Steller - Industry Principal of Life Sciences, Vistex
- Navigate historical data requirements and reporting obligations in M&A scenarios
- Manage state agency relationships during ownership transitions
- Create processes for combining disparate reporting systems post-merger
- Implement verification protocols for historical data accuracy
Deep exploration of nuanced trade class determinations in gray areas and their cascading implications for government price reporting
Updates directly from the manufacturers, vendors and CMS folks working to improve the health ecosystem from all sides. This industry group is here to answer questions on what they do, how they do it and what they are currently working on. Real resulting changes in industry are driven from this conversation with all policy suggestions submitted to CMS directly post session.
- Antoine Nelson - Director, Pharmaceutical Rebate Operations, Government Healthcare Solutions, Conduent
Who do you contact with questions for errors? Who do you contact when you need details on the process for filing this and that? Sign up your team to meet your contacts at some of the top wholesalers nationwide. These meet-and-greets are for connecting and learning the processes and needs for each stakeholder to work collaboratively together.
- Amanda Bounds - Senior Director, Contract Administration, McKesson
- Julia Williams - Senior Manager, Contract Administration (MSH), McKesson
- Michael Connelly - Vice President, Pricing & Contract Management, Cencora
Join us for Speed Networking with your industry peers and colleagues to start your journey off with as many new friends to carry you through the many learnings of the next two jam-packed days.
